Evolent Health Inc. (NYSE:EVH)’s share price dropped 2.3% on Wednesday . The company traded as low as $24.07 and last traded at $24.08, with a volume of 108,801 shares traded. The stock had previously closed at $24.64.

EVH has been the subject of a number of research reports. Jefferies Group initiated coverage on shares of Evolent Health in a research report on Tuesday, July 26th. They set a “buy” rating and a $28.00 target price for the company. Canaccord Genuity restated a “buy” rating and set a $30.00 target price on shares of Evolent Health in a research report on Sunday, August 7th. Leerink Swann restated a “buy” rating and set a $20.00 target price on shares of Evolent Health in a research report on Monday, May 16th. FBR & Co restated a “buy” rating on shares of Evolent Health in a research report on Saturday, May 14th. Finally, Zacks Investment Research upgraded shares of Evolent Health from a “sell” rating to a “hold” rating in a research report on Wednesday, May 18th. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. Evolent Health has a consensus rating of “Buy” and a consensus price target of $22.50.

The company’s 50-day moving average is $23.69 and its 200-day moving average is $15.39. The firm’s market capitalization is $1.48 billion.

Evolent Health (NYSE:EVH) last posted its earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.04. The firm had revenue of $56.50 million for the quarter, compared to analysts’ expectations of $51.96 million. During the same period last year, the firm earned ($0.95) earnings per share. Evolent Health’s revenue for the quarter was up 443.3% compared to the same quarter last year. Equities research analysts forecast that Evolent Health Inc. will post ($0.54) EPS for the current fiscal year.

An institutional investor recently raised its position in Evolent Health stock. Wells Fargo & Company MN increased its stake in Evolent Health Inc. (NYSE:EVH) by 22.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 808,909 shares of the company’s stock after buying an additional 145,685 shares during the period. Wells Fargo & Company MN owned about 1.37% of Evolent Health worth $9,796,000 at the end of the most recent quarter.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.